Nektar Therapeutics CEO Howard W. Robin Reports Disposal of Common Shares
Nektar Therapeutics CEO Howard W. Robin Reports Disposal of Common Shares Howard W. Robin, President & CEO of Nektar Therapeutics, reported a disposal of common shares of the company. The full filing can be accessed through the link below.
Howard W. Robin, President & CEO of Nektar Therapeutics, reported a disposal of common shares of the company. The full filing can be accessed through the link below.